Response to the Letter to the Editor From Dr Kawada, “Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus”

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.01.001 ◽

2020 ◽

Vol 44 (1) ◽

pp. 4 ◽

Cited By ~ 1

Author(s):

Tomoyuki Kawada

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

Bali Medical Journal ◽

10.15562/bmj.v8i3.1534 ◽

2019 ◽

Vol 8 (3) ◽

pp. 757

Author(s):

Ratih Puspita Febrinasari ◽

Bambang Irawan Martohusodo ◽

Erna Kristin ◽

Ricvan Dana Nindrea ◽

Iwan Dwiprahasto

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Diabetic Medicine ◽

10.1111/dme.14107 ◽

2019 ◽

Vol 37 (1) ◽

pp. 44-52 ◽

Cited By ~ 1

Author(s):

C. I. Coleman ◽

E. R. Weeda ◽

A. Kharat ◽

B. Bookhart ◽

W. L. Baker

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients

Aging Clinical and Experimental Research ◽

10.1007/s40520-014-0231-1 ◽

2014 ◽

Vol 26 (3) ◽

pp. 307-314 ◽

Cited By ~ 1

Author(s):

Martin Wawruch ◽

Veronika Slezakova ◽

Jan Murin ◽

Jan Luha ◽

Michal Bozik ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Receptor Blockers ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients

Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis—A nationwide cohort study

PLoS ONE ◽

10.1371/journal.pone.0188720 ◽

2017 ◽

Vol 12 (12) ◽

pp. e0188720 ◽

Cited By ~ 4

Author(s):

Ting-Tse Lin ◽

Cho-Kai Wu ◽

Min-Tsun Liao ◽

Yao-Hsu Yang ◽

Pau-Chung Chen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Myocardial Infarction ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus

Medicine ◽

10.1097/md.0000000000010256 ◽

2018 ◽

Vol 97 (15) ◽

pp. e0256 ◽

Cited By ~ 4

Author(s):

Xiaodan lv ◽

Yingshi Zhang ◽

Yixuan Niu ◽

Qi Song ◽

Qingchun Zhao

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Effect of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers on the Prevention of Death in Patients with Type 2 Diabetes and Undetermined Nephropathy : Five-Year Survival Data

Journal of Diabetes & Metabolism ◽

10.4172/2155-6156.1000188 ◽

2012 ◽

Vol 03 (04) ◽

Author(s):

Sirima Mongkolsomlit ◽

Petch Rawdaree ◽

Chulalux Komoltri

Keyword(s):

Type 2 Diabetes ◽

Survival Data ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

ANGIOTENSIN RECEPTOR BLOCKERS VS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN HYPERTENSIVE PATIENTS WITH SYSTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION

Journal of Hypertension ◽

10.1097/01.hjh.0000571188.83601.16 ◽

2019 ◽

Vol 37 ◽

pp. e82

Author(s):

S. Joo ◽

J.-G. Lee ◽

J.W. Beom ◽

J.-H. Choi ◽

S.-Y. Kim ◽

...

Keyword(s):

Myocardial Infarction ◽

Enzyme Inhibitors ◽

Systolic Dysfunction ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers benefits outweigh the risks in COVID‐19 hypertensive patients

Journal of Medical Virology ◽

10.1002/jmv.26672 ◽

2020 ◽

Author(s):

Areej Mohamed Ateya ◽

Nagwa A. Sabri

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement

Clinical and Experimental Hypertension ◽

10.1080/10641963.2021.1883051 ◽

2021 ◽

pp. 1-8

Author(s):

Cesur Samanci ◽

Bengu Saylan ◽

Gokce Gulsen ◽

Yuksel Akkaya ◽

Melike Yesildal ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Lung Involvement ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Potential Influence ◽

Hypertensive Patients ◽